CCL19 antibody (AA 22-98)

Catalog No. ABIN2618133

Product Details anti-CCL19 Antibody

Target: CCL19 (Chemokine (C-C Motif) Ligand 19 (CCL19))

Binding Specificity: AA 22-98

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This CCL19 antibody is un-conjugated

Application: Immunohistochemistry (IHC), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Specificity: Human CCL19 / MIP3-Beta

Purification: Immunoaffinity purified

Immunogen: Human recombinant protein fragment corresponding to amino acids 22-98 of human CCL19 (NP_006265) produced in E. coli.

Type of Immunogen: Recombinant protein

Clone: 2A12

Isotype: IgG1

Application Details

Application Notes: Approved: IHC, IHC-P (1:150)

Comment:

Target Species of Antibody: Human

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: Lot specific

Buffer: PBS,  pH 7.3, 1 % BSA, 50 % glycerol, 0.02 % sodium azide

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handling Advice: Minimize freezing and thawing.

Storage: -20 °C

Storage Comment: Store at -20°C. Avoid freeze-thaw cycles.

Target Details for CCL19

Target: CCL19 (Chemokine (C-C Motif) Ligand 19 (CCL19))

Alternative Name: CCL19 / MIP3-beta (CCL19 Products)

Synonyms: CKb11 antibody, ELC antibody, MIP-3b antibody, MIP3B antibody, SCYA19 antibody, CCL19 antibody, Scya19 antibody, exodus-3 antibody, C-C motif chemokine ligand 19 antibody, chemokine (C-C motif) ligand 19 antibody, CCL19 antibody, ccl19 antibody, Ccl19 antibody

Background: Name/Gene ID: CCL19
Subfamily: Intercrine beta
Family: Intercrine

Synonyms: CCL19, C-C motif chemokine 19, CKb11, CC chemokine ligand 19, EBI1 ligand chemokine, EBI1-ligand chemokine, Exodus-3, ELC, MIP-3-beta, MIP3B, SCYA19, Small-inducible cytokine A19, Beta chemokine exodus-3, Beta-chemokine exodus-3, CK beta-11, MIP-3b

Gene ID: 6363

NCBI Accession: NP_006265

Pathways: Positive Regulation of Immune Effector Process